Hyphens Pharma opens at above IPO price on Catalist debut

Hyphens Pharma opens at above IPO price on Catalist debut

Benjamin Cher
18/05/18, 12:22 pm

SINGAPORE (May 18): Hyphens Pharma International, the latest healthcare stock making it Catalist debut this morning, opened at 30 cents, 15.4% higher than its IPO price of 26 cents.

As at 11.59am, the stock was trading at 28.5 cents with some 17.4 million shares changing hands.

Hyphens Pharma has three income streams. One is the specialty pharmaceutical segment involved in the selling and marketing of specialty pharmaceutical products from brands such as Guerbet and Bausch+Lomb.

The other is the development and sale of its own range of dermatological products and health supplements under its proprietary brands segment, under the “Ceradan”, “TDF” and “Ocean Health” labels.

Yet another is the medical hypermart and digital business segment which sells medicine on a wholesale basis to clinics. It also has an e-commerce platform distributing these drugs to clinics in Singapore.

“It is not easy for an SME [small and medium enterprise] to build different streams of income. We are very fortunate to have three,” Lim See Wah, Hyphens Pharma’s chairman and CEO, tells The Edge Singapore. “[And] all the three segments are growing, although at a slightly different pace.”

To find out more about Hyphens Pharma and its business, get your copy of The Edge Singapore (Issue No. 831, week of May 21) which is on sale now.

Subscribe here

Subscribers log in and read “Hyphens Pharma seeks listing as it hunts for potential business partners, acquisitions” here

Genocide can't be good for business

SINGAPORE (Nov 19): It was only three years ago, after the watershed elections in November 2015 that saw Aung San Suu Kyi transition from democracy icon under house arrest to Myanmar’s State Counsellor and de facto leader, that Myanmar began to emerge from years of economic isolation. In 2016, the US lifted some of its economic sanctions; in 2017, there were 3.44 million tourist arrivals into the country, 18% more than the year before. Meanwhile, the Myanmar government has made considerable effort to entice foreign direct investment and spur local enterprise. It has passed new laws to mak....

Noble gets go-ahead for controversial restructuring plan, pays funds into court in ongoing legal suit

SINGAPORE (Nov 19): Troubled commodities trader Noble Group is moving ahead with a controversial restructuring plan that will see its investors’ shareholding significantly diluted and its creditors owning most of the company. Meanwhile, a former employee whom it sued for conspiracy to injure the company by unlawful means is expecting to be vindicated and compensated for his legal costs. On Nov 15, Noble said its restructuring plan had been sanctioned by the relevant courts and would proceed. According to its indicative timetable, the last date for trading in its shares is Nov 16....

Looking beyond quarterly fluctuations in ST Engineering's growth story

SINGAPORE (Nov 17): ST Engineering’s latest third-quarter results have shown improvements in profitability in three of its four key business units of aerospace, electronics, land systems and marine. In addition to the main four, there is an “others” unit, which lumps together shared services, new ventures and other related activities. It reported a loss of $7.3 million. ST Engineering’s latest third-quarter results have shown improvements in profitability in almost all its business units. The marine unit, on the other hand, suffered a 35% y-o-y drop in earnings to $12.8 millio....
BMW charges up an 'electrified future'

Christopher Wehner, managing director of BMW Group Asia, explains how electric cars such as the BMW